NEO 8-K 2026-10-05
NEOGENOMICS INC (NEO) 8-K dated 2026-10-05 — accession 0001077183-26-000069. This URL is the filing, not the NEO hub.
NEOGENOMICS INC (NEO) is a diagnostics & research company listed on US.
NEO: SECURITIES AND EXCHANGE COMMISSION
Cached items: 2.02, 5.02, 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported NEO revenue for 2025-12-31 was $727.3M. Net income was -$108.0M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. NEO currently screens at market cap $924.0M.
Not investment advice. The NEO SEC hub lists recent forms. The stock page is the research view.
- Guidance
- guidance,” “enable,” “position,” “potential” and other words of similar meaning, although not all forward-looking statements inc
Why it matters
- guidance,” “enable,” “position,” “potential” and other words of similar meaning, although not all forward-looking statements inc